Direct anti-markovnikov addition of acids to alkenes

US9365530B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9365530-B2
Application numberUS-201314397603-A
CountryUS
Kind codeB2
Filing dateMay 6, 2013
Priority dateMay 7, 2012
Publication dateJun 14, 2016
Grant dateJun 14, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method of making an anti-Markovnikov addition product is carried out by reacting an acid with an alkene or alkyne in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; the dual catalyst reaction system comprising a single electron oxidation catalyst in combination with a hydrogen atom donor catalyst. Compositions useful for carrying out such methods are also described.

First claim

Opening claim text (preview).

That which is claimed is: 1. A method of making an anti-Markovnikov addition product, comprising: reacting an aliphatic organic acid with an alkene in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; said dual catalyst reaction system comprising a single electron oxidation catalyst in combination with a hydrogen atom donor catalyst, wherein said single electron oxidation catalyst has the structure: and wherein said hydrogen atom donor catalyst has the structure: 2. The method of claim 1 , wherein said reacting is an intramolecular hydroalkoxylation reaction. 3. The method of claim 1 , wherein said reacting is an intramolecular hydrolactonization reaction. 4. The method of claim 1 , wherein said reacting is an intermolecular hydroacetoxylation reaction. 5. The method of claim 1 , wherein said reacting is an anti-Markovnikov polymerization reaction where the acid and alkene group are contained within the same monomeric unit or are contained on separate monomeric units.

Assignees

Inventors

Classifications

  • not condensed with other rings · CPC title

  • Nitrogen containing compounds · CPC title

  • Operations & Transport · mapped topic

  • with nitrogen contained as ring member in aromatic compounds or moieties, e.g. pyridine · CPC title

  • Cyclisations via conversion of C-C multiple to single or less multiple bonds, e.g. cycloadditions · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9365530B2 cover?
A method of making an anti-Markovnikov addition product is carried out by reacting an acid with an alkene or alkyne in a dual catalyst reaction system to the exclusion of oxygen to produce said anti-Markovnikov addition product; the dual catalyst reaction system comprising a single electron oxidation catalyst in combination with a hydrogen atom donor catalyst. Compositions useful for carrying o…
Who is the assignee on this patent?
Univ North Carolina
What technology area does this patent fall under?
Primary CPC classification C07D307/12. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).